← All companies

SLBT

SL Science Holding Limited

SLBT Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$3.08

-0.21 -6.38%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$0.00

Total assets

$11.8K

Gross margin

—

52-week range

$2.54 – $14.50

Recent SEC filings

30 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 10, 2026 20-F ANNUAL REPORT Jun 18, 2026 6-K FORM 6-K Jun 15, 2026

Other filings

F-1 Jul 31, 2026 SCHEDULE 13D Jun 18, 2026 3 OWNERSHIP DOCUMENT Jun 18, 2026 3 OWNERSHIP DOCUMENT Jun 17, 2026 3 OWNERSHIP DOCUMENT Jun 16, 2026 3 OWNERSHIP DOCUMENT Jun 16, 2026 3 OWNERSHIP DOCUMENT Jun 16, 2026 3 OWNERSHIP DOCUMENT Jun 16, 2026 3 OWNERSHIP DOCUMENT Jun 16, 2026 3 OWNERSHIP DOCUMENT Jun 16, 2026 3 PRIMARY DOCUMENT Jun 15, 2026 CERT Jun 12, 2026 8-A12B FOR REGISTRATION OF CERTAIN CLASSES Jun 11, 2026 425 FORM 425 Mar 24, 2026 425 FORM 425 Feb 18, 2026 425 FORM 425 Feb 6, 2026 425 FORM 425 Feb 3, 2026 425 FORM 425 Jan 30, 2026 425 FORM 425 Jan 15, 2026 EFFECT Jan 13, 2026 424B3 PROSPECTUS Jan 13, 2026 F-4/A REGISTRATION STATEMENT Jan 7, 2026 F-4 REGISTRATION STATEMENT Dec 18, 2025 DRS/A Nov 14, 2025 DRS/A Sep 10, 2025 DRS/A Jul 16, 2025 DRS Jun 13, 2025